GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Accumulated other comprehensive income (loss)

ATAI Life Sciences NV (FRA:9VC) Accumulated other comprehensive income (loss) : €-17.41 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. ATAI Life Sciences NV's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-17.41 Mil.

ATAI Life Sciences NV's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-17.91 Mil) to Dec. 2023 (€-17.85 Mil) and increased from Dec. 2023 (€-17.85 Mil) to Mar. 2024 (€-17.41 Mil).

ATAI Life Sciences NV's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-7.38 Mil) to Dec. 2022 (€-20.49 Mil) but then increased from Dec. 2022 (€-20.49 Mil) to Dec. 2023 (€-17.85 Mil).


ATAI Life Sciences NV Accumulated other comprehensive income (loss) Historical Data

The historical data trend for ATAI Life Sciences NV's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Accumulated other comprehensive income (loss) Chart

ATAI Life Sciences NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
-1.28 4.78 -7.38 -20.49 -17.85

ATAI Life Sciences NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.45 -19.22 -17.91 -17.85 -17.41

ATAI Life Sciences NV Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


ATAI Life Sciences NV Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


ATAI Life Sciences NV (FRA:9VC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
Address
Wallstraße 16, Berlin, BB, DEU, 10179
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

ATAI Life Sciences NV (FRA:9VC) Headlines

No Headlines